Article Sidebar
Main Article Content
Alopecia in Patients with Autoimmune Hepatitis Treated by Tacrolimus Therapy
Main Article Content
Abstract
Cite this article as: Yüksekyayla O, Batıbay E, Wahlin S, Efe C. Alopecia in patients with autoimmune hepatitis treated by tacrolimus therapy. Turk J Gastroenterol. 2025;36(1):67-68.
Article Details
References
1. Özaslan E, Günşar F, Çiftçibaşı Örmeci A, et al. Diagnosis and treatment of autoimmune hepatitis: questions, answers, and illustrative cases: endorsed by autoimmune liver diseases Special Interest Group, Turkish association for the study of liver. Turk J Gastroenterol. 2023;34:S1-S33. [CrossRef]
2. Yassin W, Nasser R, Veitsman E, Saadi T. The effectiveness of measuring thiopurine metabolites in the treatment of autoimmune hepatitis patients. Turk J Gastroenterol. 2024;35(3):232-238. [CrossRef]
3. Tricot L, Lebbé C, Pillebout E, Martinez F, Legendre C, Thervet E. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation. 2005;80(11):1546-1549. [CrossRef]
4. Alatas FS, Matsuura T, Yoshimaru K, Kadim M, Taguchi T. Alopecia in children following living related liver transplantation. Transplant Proc. 2021;53(1):228-232. [CrossRef]
5. Terziroli Beretta-Piccoli B, Invernizzi P, Gershwin ME, Mainetti C. Skin manifestations associated with autoimmune liver diseases: a systematic review. Clin Rev Allergy Immunol. 2017;53(3):394-412. [CrossRef]
6. Talbot D, Rix D, Abusin K, Mirza D, Manas D. Alopecia as a consequence of tacrolimus therapy in renal transplantation? Transplantation. 1997;64(11):1631-1632. [CrossRef]